The authors conducted an analytical cross-sectional study over a period of 3 months among hypertensive patients, in order to determine the frequency of the erectile dysfunction (ED), and to identify the predictive factors. It included treated hypertensive patients, presenting an ED, defined as the incapacity to obtain or maintain an erection sufficient for satisfactory sexual activity. On 265 hypertensive patients, 172 (65%) presented an ED. The average age was 58.2 ± 9.7 years. The associated cardiovascular risk factors were overweight/obesity in 99 cases (37.4%), sedentariness in 90 cases (34%), diabetes mellitus in 50 cases (19%), dyslipidemia in 12 cases (4.5%), and tobacco addiction in 6 cases (2.3%). Arterial hypertension (HTN), old of 6.7 ± 5.8 years, was treated by bitherapy in 129 cases (48.7%), and tritherapy in 102 cases (38.5%). The principal therapeutic classes used were ACE inhibitors/ARBs in 213 cases (81%), calcium antagonists in 205 cases (78%), thiazides in 137 cases (52.1%), and beta-blockers in 82 cases (31%). ED, severe in 124 cases (72%), and moderate in 48 cases (28%), consisted of a difficulty to maintain the erection in 78 cases (45.3%), to obtain the erection in 30 cases (17.4%), and the two partners in 64 cases (37.2%). In multivariate analysis, only the age, seniority of HTN, and the existence of diabetes mellitus were the predictive factors of ED. The early and effective assumption of responsibility of the AHT, as well as other cardiovascular risk factors whose diabetes, would make it possible to reduce the frequency of it, thus improving quality of life of the hypertensive patients.
Introduction
Arterial hypertension (HTN) is a major cardiovascular risk factor, and constitutes true public health problems in the world, concerning close to the 1/3 of the population adult, and responsible for roughly 7.6 million annual deaths [1] [2] .
Pathology with chronic evolution, it poses problems of the management to the long course because of the serious complications, and the side-effects of the antihypertensive drugs, with a negative impact on the adherence medication, and an increased risk of abandonment [3] . The association HTN and erectile dysfunction (ED) is frequent, and constitute a major concern for the experts, because of the deterioration of the quality of life of the patients [4] [5] [6] . In sub-Saharan Africa, few studies were brought back on the subject [7] [8] . In Congo, this preliminary study targeting at improving the management of the hypertensive patients aimed to determine the frequency of ED in the HTN, and to identify the predictive factors of ED.
Patients and Methods
It was about an analytical cross-sectional study with a prospective data collection, carried out in the unit of external consultations of the service of cardiology and internal medicine of the University Hospital of Brazzaville. It was held from May 1 st to July 31 st , 2015 (either three months). It included a consecutive series of hypertensive patients known and treated, followed into ambulatory, presenting one ED, defined as the incapacity to obtain and/or maintain an erection effective for a satisfactory sexual activity. The score of the International Index on the Erectile Function (IIEF) [9] allowed evaluating the degree of severity of ED. 
Results

Epidemiological Trends
Of the 265 patients, 172 presented an ED, that is to say, a frequency of 65%. The median age of the patients was 58. Table 2 gives the results of the logistic regression.
Discussion
The erectile dysfunction (ED) is a frequent comorbidity during arterial hypertension (HTN), as noted in our study at more half of the patients, with various degrees of severity. In the literature, its prevalence is very variable, between 40 Indeed, during these cardiovascular pathologies, ED can, in some case, to pre-exist before occurred of the cardiovascular event, and others, to occur with the waning of the event, in varying proportions according to the nature of the event [16] . It was shown in this first case of the figure that the percentage occurred of cardiovascular events increased in a way proportional to the seniority of ED [16] . Concerning the HTN, it is known that the prevalence of being more important among hypertensive patients, a fortiori at those treated, compared to the none hypertensive subjects [17] - [24] , and this whatever is the degree of severity [24] . Of psychogenic or organic origin, ED among hypertensive patients can be various mechanisms [15] . Indeed, if atherosclerosis, by the means of HTN and associated other risk factors seems to play a paramount role, the harmful effect of the antihypertensive agents is not to ignore [25] [33]. In addition to their beneficial effect on the improvement of the quality of life of the patients, this therapeutic class also contributes to improving medication adherence of antihypertensive drugs [34] and leaving a better blood pressure level control [35] . In our series, the still frequent recourse to the alternative treatments such as herb teas, and the weak use of the PDE-5 inhibitors constitute an obstacle with the optimal management of the hypertensive patients suffering from ED in our context.
Conclusion
It comes out from this study that the erectile dysfunction is a frequent comorbidity among hypertensive patients. It is about a pathology little known, underestimated, and undertreated in this population, where arterial hypertension plays a paramount role in its occurred, but also certain antihypertensive drugs.
The early tracking of, the effective management of arterial hypertension and as-World Journal of Cardiovascular Diseases sociated cardiovascular risk factors, the rational use of the PDE-5 inhibitors will contribute to improving to become to it patients; from where the need for a multi-field collaboration associating cardiologists and uro-andrologists.
